Abstract
The serotonin syndrome, a behavioral response produced by the activation of serotonin receptors, and 3H-serotonin binding were examined after repeated treatment of rats with different types of antidepressant drugs. The serotonin syndrome was produced by the direct-acting serotonin receptor agonists 5-methoxy-N,N-dimethyltryptamine (5-MeDMT) or d-lysergic acid diethylamide (LSD). Repeated, but not acute treatment of rats with monoamine oxidase inhibitors (nialamide, pargyline, and phenelzine) prevented the serotonin syndrome in response to either 5-MeDMT or LSD and also reduced 3H-serotonin binding in the brain stem and spinal cord. Pretreatment of rats with p-chlorophenylalanine blocked the ability of nialamide treatment to inhibit the serotonin syndrome caused by 5-MeDMT. By contrast, neither the serotonin syndrome or 3H-serotonin binding was affected significantly by the repeated administration of tricyclic antidepressants (amitriptyline, desmethyl-imipramine, and chlorimipramine) or iprindole. Repeated monoamine oxidase inhibitor treatments may prevent the serotonin syndrome by causing a reduction of 3H-serotonin receptor binding sites in the brain stem and/or spinal cord.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aprison MH, Takahashi R, Tachiki K (1978) Hypersensitive serotonergic receptors involved in clinical depression: A theory. In: Aprison MH (ed) Neuropharmacology and behavior. Plenum, New York, pp 25–53
Banerjee SP, Kung LS, Riggi SJ, Chanda SK (1977) Development of β-adrenergic receptor subsensitivity by antidepressants. Nature 268:455–456
Bennett JP Jr, Snyder SH (1976) Serotonin and lysergic acid diethylamide binding in rat brain membranes: Relationship to postsynaptic serotonin receptors. Mol Pharmacol 12:373–389
Deakin JFW, Green AR (1978) The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-Dopa to rats. Br J Pharmacol 64:201–209
De Montigny D, Aghajanian GK (1978) Tricyclic antidepressants: Long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202:1303–1305
Frazer A (1981) Antidepressant drugs: Effect on adrenergic responsiveness and monoamine receptors. In: Usdin E, Bunney WE, Davis JM (eds) Neuroreceptors: Basic and clinical aspects. Wiley, New York, pp 85–98
Frazer A, Pandey G, Mendels J, Neeley S, Kane M, Hess ME (1974) The effect of tri-iodothyronine in combination with imipramine on [3H]-cyclic AMP production in slices of rat cerebral cortex. Neuropharmacology 13:1131–1140
Friedman E, Dallob A (1979) Enhanced serotonin receptor activity after chronic treatment with imipramine or amitriptyline. Commun Psychopharmacol 3:93–99
Grahame-Smith DG (1971) Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem 18:1053–1066
Jacobs BL (1974) Effect of two dopamine receptor blockers on a serotonin-mediated behavioral syndrome in rats. Eur J Pharmacol 27:363–366
Jacobs BL (1976) An animal behavior model for studying central serotonergic synapses. Life Sci 19:777–786
Jacobs BL, Klemfuss H (1975) Brain stem and spinal cord mediation of a serotonergic behavioral syndrome. Brain Res 100:450–457
Koe BK, Weissman A (1966) p-Chlorophenylalanine: A specific depletor of brain serotonin. J Pharmacol Exp Ther 154:499–516
Leysen JE (1981) Serotonergic receptors in brain tissue: Properties and identification of various 3H-ligand binding sites in vitro. J Physiol (Paris) 77:351–362
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Mogilnicka E, Klimek V (1979) Mianserin, danitracen and amitriptyline withdrawal increases the behavioral responses of rats to L-5-HTP. J Pharm Pharmacol 31:704–705
Moyer JA, Greenberg LH, Frazer A, Weiss B (1981) Subsensitivity of the beta-adrenergic receptor-linked adenylate cyclase system of rat pineal gland following repeated treatment with desmethylimipramine and nialamide. Mol Pharmacol 19:187–193
Nelson D, Herbert A, Bourgoin S, Glowinski J, Hamon H (1978) Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol 14:983–995
Oswald I, Brezinova V, Dunleavy DLF (1972) On the slowness of action of tricyclic antidepressant drugs. Br J Psychiatry 120:673–677
Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple 3H-5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem 36:220–226
Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: Differential binding of 3H-5-hydroxytryptamine, 3H-lysergic acid diethylamide, and 3H-spiroperidol. Mol Pharmacol 16:687–699
Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210:88–90
Peroutka SJ, Lebovitz RM, Snyder SH (1981) Two distinct central serotonin receptors with different physiological functions. Science 212:828–829
Quitkin F, Rifkin A, Klein DF (1979) Monoamine oxidase inhibitors. Arch Gen Psychiatry 36:749–760
Resnick O, Kurs DM, Raskin M (1964) LSD-25 action in normal subjects treated with a monoamine oxidase inhibitor. Life Sci 3:1207–1214
Robinson DS, Nies A, Ravaris CL, Ives JO, Bartlett D (1978) Clinical pharmacology of phenelzine. Arch Gen Psychiatry 35:629–635
Sai-Halasz A (1963) The effect of MAO inhibition on the experimental psychosis induced by dimethyltryptamine. Psychopharmacologia 4:385–388
Savage DD, Frazer A, Mendels J (1979) Differential effects of monoamine oxidase inhibitors and serotonin reuptake inhibitors on 3H-serotonin receptor binding in rat brain. Eur J Pharmacol 55: 87–88
Savage DD, Mendels J, Frazer A (1980a) Monoamine oxidase inhibitors and serotonin uptake inhibitors: Differential effects on 3H-serotonin binding sites in rat brain. J Pharmacol Exp Ther 212:259–263
Savage DD, Mendels J, Frazer A (1980b) Decrease in 3H-serotonin binding in rat brain produced by the repeated administration of either monoamine oxidase inhibitors or centrally acting serotonin agonists. Neuropharmacology 19:1063–1070
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672
Sloviter RS, Drust EG, Connor JD (1978) Specificity of a rat behavioral model for serotonin receptor activation. J Pharmacol Exp Ther 206:339–347
Sloviter RS, Drust EG, Damiano BP, Conner JD (1980) A common mechanism for lysergic acid, indole alkylamine and phenethylamine hallucinogens: Serotonergic mediation of behavioral effects in rats. J Pharmacol Exp Ther 214:231–238
Trulson ME, Eubanks EE, Jacobs BL (1976) Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine. J Pharmacol Exp Ther 198:23–32
Vetulani J, Sulser F (1975) Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature 257:495–496
Wirz-Justice A, Krauchi K, Lichsteiner M, Feer H (1978) Is it possible to modify serotonin receptor sensitivity? Life Sci 23:1249–1254
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lucki, I., Frazer, A. Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants. Psychopharmacology 77, 205–211 (1982). https://doi.org/10.1007/BF00464567
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00464567